Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy

Clinical trial NCT01450683 · TERMINATED

Trial details

NCT number: NCT01450683
Sponsor: Stanford University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Prostatic Neoplasms Castrate-resistant Prostate Cancer (CRPC)Androgen-insensitive Prostate Cancer Hormone-refractory Prostate Cancer Metastatic Disease

Start date: 2010-09-01
Primary completion: 2011-04-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.